Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT06218420
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years old
* Patients enlisted for LT in France for HCC (under Agence de Biomédecine (ABM) regulation)
* HCC previously treated by ablation/surgery/TACE or naive
* Not suitable for another bridging therapy such as liver resection, ablation therapy, or TACE (discussed in multidisciplinary meeting within a transplant center)
* Suitable for stereotactic radiotherapy:
* ECOG, performance status score ≤ 2,
* Child-Pugh Score ≤ B7,
* Number of lesions between 1 and 3
* Maximum tumor size \< 5cm Liver remnant volume ≥ 700 ml.
* Health insurance coverage.
* Written informed consent
Exclusion Criteria:
* Inability to comply with study procedures
* Patients under guardianship or curatorship
* Pregnancy (negative urinary/blood βHCG test)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06218420
Study Brief:
Protocol Section:
NCT06218420